Wall Street Zen upgraded shares of Brookfield (NYSE:BN – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday morning. A number of other equities research analysts have also issued reports on the company. Morgan Stanley set a $54.00 price target on Brookfield and gave the […]

Wall Street Zen downgraded shares of PepsiCo (NASDAQ:PEP – Free Report) from a buy rating to a hold rating in a research report sent to investors on Saturday morning. PEP has been the subject of a number of other research reports. Piper Sandler upped their price objective on PepsiCo from $161.00 to $172.00 and gave […]

Wall Street Zen upgraded shares of Belite Bio (NASDAQ:BLTE – Free Report) from a sell rating to a hold rating in a report released on Saturday morning. Several other research firms have also recently commented on BLTE. Cantor Fitzgerald started coverage on shares of Belite Bio in a report on Monday, November 24th. They set […]

Wall Street Zen upgraded shares of Flex LNG (NYSE:FLNG – Free Report) from a sell rating to a hold rating in a report released on Saturday. Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Flex LNG in a research report on Monday, December 22nd. Three investment analysts have rated the stock with […]

Wall Street Zen lowered shares of Heico (NYSE:HEI – Free Report) from a buy rating to a hold rating in a research report report published on Saturday morning. Other analysts have also issued research reports about the company. Weiss Ratings reiterated a “buy (b-)” rating on shares of Heico in a report on Monday, December […]

Wall Street Zen upgraded shares of Voya Financial (NYSE:VOYA – Free Report) from a hold rating to a buy rating in a research report report published on Saturday. VOYA has been the topic of a number of other reports. Keefe, Bruyette & Woods cut their price target on shares of Voya Financial from $86.00 to […]

Wall Street Zen upgraded shares of Ovid Therapeutics (NASDAQ:OVID – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday morning. Other equities research analysts have also issued research reports about the stock. Roth Capital assumed coverage on shares of Ovid Therapeutics in a report on […]

Wall Street Zen upgraded shares of Acadia Realty Trust (NYSE:AKR – Free Report) from a sell rating to a hold rating in a report issued on Saturday. Several other equities research analysts have also recently weighed in on the stock. Truist Financial cut their price objective on shares of Acadia Realty Trust from $23.00 to […]

BCE (NYSE:BCE – Get Free Report) (TSE:BCE) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Sunday. BCE has been the topic of several other research reports. BMO Capital Markets raised shares of BCE from a “market perform” […]

Wall Street Zen downgraded shares of Sandisk (NASDAQ:SNDK – Free Report) from a strong-buy rating to a buy rating in a research note published on Saturday. Other analysts have also recently issued research reports about the stock. Benchmark restated a “buy” rating on shares of Sandisk in a research note on Thursday, December 18th. Susquehanna […]

Synaptics (NASDAQ:SYNA – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Sunday. SYNA has been the topic of a number of other research reports. Northland Securities began coverage on Synaptics in a report […]

Wall Street Zen upgraded shares of Marine Products (NYSE:MPX – Free Report) to a hold rating in a research note published on Saturday. Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Marine Products in a research report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, […]

Wall Street Zen upgraded shares of Bright Minds Biosciences (NASDAQ:DRUG – Free Report) from a sell rating to a hold rating in a research note published on Saturday. A number of other analysts have also recently issued reports on the company. BTIG Research began coverage on Bright Minds Biosciences in a research report on Monday, […]

Leslie’s (NASDAQ:LESL – Get Free Report) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Sunday. A number of other research analysts have also issued reports on LESL. Weiss Ratings reiterated a “sell (e+)” rating on shares of Leslie’s in a research report […]

Wall Street Zen cut shares of SEACOR Marine (NYSE:SMHI – Free Report) from a buy rating to a hold rating in a research note published on Saturday. Other research analysts have also issued research reports about the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of SEACOR Marine in a research report on […]

Wall Street Zen lowered shares of NPK International (NYSE:NPKI – Free Report) from a buy rating to a hold rating in a research report released on Saturday. NPKI has been the subject of several other research reports. HC Wainwright raised their price target on shares of NPK International from $12.00 to $18.00 and gave the […]

Wall Street Zen upgraded shares of Senstar Technologies (NASDAQ:SNT – Free Report) to a hold rating in a research report released on Saturday. Separately, Weiss Ratings restated a “hold (c+)” rating on shares of Senstar Technologies in a research report on Tuesday, December 16th. One equities research analyst has rated the stock with a Hold […]

Wall Street Zen lowered shares of Boxlight (NASDAQ:BOXL – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday morning. Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Boxlight in a research report on Tuesday, October 14th. One investment analyst has rated the […]

Wall Street Zen upgraded shares of Sensei Biotherapeutics (NASDAQ:SNSE – Free Report) to a hold rating in a research note published on Saturday morning. Other research analysts have also issued reports about the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Sensei Biotherapeutics in a research note on Monday, December 22nd. HC […]

Wall Street Zen upgraded shares of Coca Cola Femsa (NYSE:KOF – Free Report) from a hold rating to a buy rating in a research note released on Saturday. A number of other equities analysts have also recently issued reports on the company. Barclays reaffirmed an “equal weight” rating and issued a $98.00 target price on […]

Freightcar America (NASDAQ:RAIL – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Sunday. Other research analysts have also issued reports about the company. Weiss Ratings lowered Freightcar America from a “hold (c-)” rating to a “sell (d+)” […]

Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Sunday. Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research note on […]

CLEAR Secure, Inc. (NYSE:YOU – Get Free Report) has been given an average rating of “Hold” by the nine ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating on the company. […]

Atmus Filtration Technologies (NYSE:ATMU – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Sunday. Several other equities research analysts have also weighed in on ATMU. JPMorgan Chase & Co. upgraded shares of Atmus […]

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating, six have assigned a buy rating and one […]

Wall Street Zen lowered shares of Tvardi Therapeutics (NASDAQ:TVRD – Free Report) from a hold rating to a sell rating in a research report released on Monday morning. A number of other research firms also recently weighed in on TVRD. Raymond James Financial downgraded shares of Tvardi Therapeutics from an “outperform” rating to a “market […]

Wall Street Zen cut shares of Super Group (SGHC) (NYSE:SGHC – Free Report) from a strong-buy rating to a buy rating in a report issued on Saturday. Several other research analysts have also recently weighed in on the company. Benchmark lowered their price objective on Super Group (SGHC) from $18.00 to $17.00 and set a […]

Shares of TAT Technologies Ltd. (NASDAQ:TATT – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and six have issued a buy rating on the company. The average 12 month […]

Wall Street Zen cut shares of Mobile Infrastructure (NASDAQ:BEEP – Free Report) to a strong sell rating in a research note released on Saturday morning. Several other equities analysts have also recently weighed in on the stock. Barrington Research reaffirmed an “outperform” rating and set a $6.50 price target on shares of Mobile Infrastructure in […]

Vertical Aerospace Ltd. (NYSE:EVTL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six brokerages that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating and five have given a buy rating to the company. The average 1 year […]

Wall Street Zen upgraded shares of OFS Credit (NASDAQ:OCCI – Free Report) from a hold rating to a buy rating in a research report sent to investors on Monday. OFS Credit Stock Performance OCCI opened at $4.74 on Monday. OFS Credit has a 1 year low of $4.31 and a 1 year high of $7.35. […]

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) has earned a consensus rating of “Reduce” from the eight research firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company. The average 12-month target […]

Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The average 1 year […]

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy […]